PMID- 29609167
OWN - NLM
STAT- MEDLINE
DCOM- 20190318
LR  - 20190318
IS  - 1873-5967 (Electronic)
IS  - 1386-6532 (Linking)
VI  - 103
DP  - 2018 Jun
TI  - Varicella Zoster Immunoglobulin G (VZIG)-Do current guidelines advocate overuse?
PG  - 25-26
LID - S1386-6532(18)30070-2 [pii]
LID - 10.1016/j.jcv.2018.03.007 [doi]
FAU - Harrington, David
AU  - Harrington D
AD  - Department of Virology, Royal Free Hospital, Pond Street, London, NW3 2QG, United 
      Kingdom. Electronic address: davidharrington@nhs.net.
FAU - Haque, Tanzina
AU  - Haque T
AD  - Department of Virology, Royal Free Hospital, Pond Street, London, NW3 2QG, United 
      Kingdom.
LA  - eng
PT  - Letter
DEP - 20180320
PL  - Netherlands
TA  - J Clin Virol
JT  - Journal of clinical virology : the official publication of the Pan American 
      Society for Clinical Virology
JID - 9815671
RN  - 0 (Antiviral Agents)
RN  - 0 (Immune Sera)
RN  - 0 (Immunoglobulin G)
RN  - 0 (varicella-zoster immune globulin)
RN  - X4HES1O11F (Acyclovir)
SB  - IM
MH  - Acyclovir/administration & dosage
MH  - Antiviral Agents/*administration & dosage
MH  - Environmental Exposure
MH  - Humans
MH  - Immune Sera/*administration & dosage
MH  - Immunocompromised Host
MH  - Immunoglobulin G/*administration & dosage
MH  - Practice Guidelines as Topic
MH  - *Prescription Drug Overuse
EDAT- 2018/04/03 06:00
MHDA- 2019/03/19 06:00
CRDT- 2018/04/03 06:00
PHST- 2017/11/28 00:00 [received]
PHST- 2018/02/23 00:00 [revised]
PHST- 2018/03/18 00:00 [accepted]
PHST- 2018/04/03 06:00 [pubmed]
PHST- 2019/03/19 06:00 [medline]
PHST- 2018/04/03 06:00 [entrez]
AID - S1386-6532(18)30070-2 [pii]
AID - 10.1016/j.jcv.2018.03.007 [doi]
PST - ppublish
SO  - J Clin Virol. 2018 Jun;103:25-26. doi: 10.1016/j.jcv.2018.03.007. Epub 2018 Mar 
      20.